% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • devineinstallationllc devineinstallationllc Jul 9, 2013 3:27 PM Flag


    I see no way that Celldex does not either A) get acquired or B) trade significantly higher.

    Up until this point, most, if not all, of its one-year 280% gains has been related to the survival data from its breast cancer drug. But luckily, the company has another Phase 3 drug that has flown under-the-radar, a product that should be dominating all the headlines within the next few months, rindopepimut. Hence, I say this rally is not even close to being over.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • temporal Jul 9, 2013 3:49 PM Flag

      Is it even a "rally" or just steady, continuous, healthy growth? Up around 6% over the last 5 days and -- if you cut out Friday which was probably somewhat anomalous given a Friday after a holiday (I think a lot of stocks saw unusual activity that day) -- there is just a continuous smooth line of ascent. We do shoot up every now and then, but, after some leveling off there is just the nice, healthy, regular increase that has been CLDX's growth patter for over a year. Where we're going fireworks aren't even necessary now (though fun); we (longs) are just persistently reminded we are going in the right direction in the long run

      Sentiment: Strong Buy

    • Just scratching the surface! This is about to go thru the roof! Coiled spring!

    • I just read the MF article and it certainly is encouraging for down the road share price appreciation. Thanks for reporting on it.

12.70-0.12(-0.94%)Oct 13 4:00 PMEDT